Prelude Financial Statements From 2010 to 2026

Prelude Therapeutics Balance Sheet		Trends
Current Value Last Year Historical Average  10 Year Trend Total Assets 195 M 201.8 M 104 M Slightly volatile Other Current Liabilities 10.2 M 17.5 M 6 M Slightly volatile Total Current Liabilities 16.8 M 29.5 M 10.2 M Slightly volatile Other Liabilities 4.1 M 3.9 M 1.3 M Slightly volatile Property Plant And Equipment Net 42.8 M 40.8 M 10.6 M Slightly volatile Accounts Payable 5.4 M 8.9 M 3.5 M Slightly volatile Cash 10.7 M 11.2 M 29.4 M Pretty Stable Non Current Assets Total 47.8 M 45.6 M 12.5 M Slightly volatile Cash And Short Term Investments 174.8 M 153.7 M 92.1 M Slightly volatile Common Stock Shares Outstanding 48.5 M 87.2 M 26.9 M Slightly volatile Liabilities And Stockholders Equity 195 M 201.8 M 104 M Slightly volatile Non Current Liabilities Total 17.5 M 16.6 M 28.3 M Slightly volatile Total Liabilities 28.6 M 39.7 M 37.2 M Pretty Stable Property Plant And Equipment Gross 49.2 M 46.8 M 11.9 M Slightly volatile Total Current Assets 177.2 M 156.3 M 93.3 M Slightly volatile Non Current Liabilities Other 1.8 M 3.6 M 1.1 M Slightly volatile Net Working Capital 160.4 M 126.8 M 83.1 M Slightly volatile Property Plant Equipment 8.1 M 7.7 M 3.1 M Slightly volatile Short and Long Term Debt Total 21.8 M 20.7 M 5 M Slightly volatile Other Current Assets 2.8 M 2.6 M 1.9 M Slightly volatile Short Term Debt 1.8 M 3.1 M 996.5 K Slightly volatile Non Currrent Assets Other 5 M 4.8 M 2.1 M Slightly volatile Other Assets 11.4 M 10.8 M 3.4 M Slightly volatile Common Stock Total Equity 3.2 K 3.6 K 3.9 K Slightly volatile Deferred Long Term Liabilities 240.8 K 270.9 K 295.7 K Slightly volatile Common Stock 5.3 K 5.8 K 4.4 K Slightly volatile Current Deferred Revenue 11.9 M 13.3 M 14.6 M Slightly volatile
Prelude Therapeutics Income Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Depreciation And Amortization 2.1 M 2 M 683.7 K Slightly volatile Selling General Administrative 20.7 M 33 M 12 M Slightly volatile Other Operating Expenses 97.1 M 168.7 M 59 M Slightly volatile Research Development 76.4 M 135.7 M 47 M Slightly volatile Cost Of Revenue 1.5 M 2 M 822.9 K Slightly volatile Total Operating Expenses 97.1 M 168.7 M 59 M Slightly volatile Reconciled Depreciation 2.1 M 2 M 685.5 K Slightly volatile Total Other Income Expense Net 15.1 M 14.4 M 4 M Slightly volatile Selling And Marketing Expenses 935.2 K 1.1 M 1.1 M Slightly volatile
Prelude Therapeutics Cash Flow Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Stock Based Compensation 15.7 M 24.5 M 8.3 M Slightly volatile Begin Period Cash Flow 57.2 M 33.7 M 32 M Slightly volatile Depreciation 2.1 M 2 M 683.7 K Slightly volatile Capital Expenditures 834.7 K 878.6 K 1 M Slightly volatile End Period Cash Flow 14.1 M 14.9 M 30.8 M Pretty Stable Change To Netincome 35.6 M 33.9 M 11.2 M Slightly volatile
Financial Ratios		Trends
Current Value Last Year Historical Average  10 Year Trend Price To Sales Ratio 11.0 12.38 13.5106 Slightly volatile Stock Based Compensation To Revenue 2.44 2.74 2.9953 Slightly volatile Capex To Depreciation 0.47 0.5 2.6098 Slightly volatile EV To Sales 8.62 9.69 10.5783 Slightly volatile Payables Turnover 0.088 0.0985 0.1075 Slightly volatile Sales General And Administrative To Revenue 3.28 3.69 4.03 Slightly volatile Research And Ddevelopement To Revenue 13.49 15.17 16.5592 Slightly volatile Capex To Revenue 0.088 0.0982 0.1073 Slightly volatile Cash Per Share 1.93 2.03 6.7408 Slightly volatile Days Payables Outstanding 2.7 K 3 K 3.3 K Slightly volatile Income Quality 0.91 0.93 0.8638 Pretty Stable Current Ratio 8.1 4.77 7.9237 Pretty Stable Capex Per Share 0.011 0.0116 0.1919 Slightly volatile Revenue Per Share 0.0738 0.0831 0.0907 Slightly volatile Interest Debt Per Share 0.22 0.21 0.067 Slightly volatile Debt To Assets 0.097 0.0924 0.0289 Slightly volatile Days Of Payables Outstanding 2.7 K 3 K 3.3 K Slightly volatile Ebt Per Ebit 1.05 0.9102 0.9777 Very volatile Quick Ratio 8.1 4.77 7.9237 Pretty Stable Cash Ratio 0.53 0.56 5.074 Slightly volatile Free Cash Flow Operating Cash Flow Ratio 1.13 1.16 1.0474 Slightly volatile Fixed Asset Turnover 0.16 0.18 0.1942 Slightly volatile Debt Ratio 0.097 0.0924 0.0289 Slightly volatile Price Sales Ratio 11.0 12.38 13.5106 Slightly volatile Asset Turnover 0.0319 0.0359 0.0392 Slightly volatile
Prelude Therapeutics Valuation Data		Trends
Current Value Last Year Historical Average  10 Year Trend Market Cap 76.3 M 80.3 M 247.3 M Pretty Stable Enterprise Value 82.3 M 86.7 M 222.2 M Pretty Stable

Prelude Fundamental Market Drivers

Prelude Upcoming Events

About Prelude Therapeutics Financial Statements

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Prelude Therapeutics is a strong investment it is important to analyze Prelude Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Prelude Therapeutics' future performance. For an informed investment choice regarding Prelude Stock, refer to the following important reports:

How To Invest In Prelude Details

Is Prelude Stock a good investment? Details

What is Prelude Therapeutics' Net Worth? Details

Largest Biotechnology Companies View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies View

Altman Z Score Details

Piotroski F Score Details

Beneish M Score Details

Financial Analysis Details

Buy or Sell Advice Details

Earnings Projections Details